Conversely, FADS2 expression is up-regulated in the adrenal glands of obese mice and in aldosterone-producing adenomas compared to non-active adenomas (producing low amounts of aldosterone) and nontumorous adrenocortical tissue of patients, while FADS2 inhibition reduces corticoid levels in obese mice. This evidence concerns the gene FADS2 and adenoma.